Clarus Therapeutics Holdings Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2022, Clarus Therapeutics Holdings's inventory turnover ratio sequentially decreased to 0.25 in the second quarter 2022, unsurprisingly, as the Clarus Therapeutics Holdings markets continue to deteriorate, and CRXT's faces growing challenges to bring down its inventories. Clarus Therapeutics Holdings's average inventory processing period in the Jun 30 2022 quarter, has increased to 1460 days, from 1259 days, in the Mar 31 2022 quarter.

Within Healthcare sector 434 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 2095 in the first quarter 2022, to 2106.

CRXT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Clarus Therapeutics Holdings Inc. Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CRXT Inventory Turnover Ratio	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter
Y / Y Inventory Growth	-	-	142.68 %	-	-
Y / Y Cost of Sales Growth	109.39 %	80.93 %	-84.71 %	98.44 %	-
Inventory Turnover Ratio (TTM)	0.25	0.29	0.41	2.15	-
CRXT's Total Ranking	# 2106	# 2095	# 2098	# 0	# 1934
Average inventory processing period	1472	1259	896	170	-
Seq. Inventory Growth	12.56 %	5.04 %	13.89 %	-	-
Seq. Cost of Sales Growth	74.7 %	-48.49 %	152.75 %	-7.94 %	50.95 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 30
Healthcare Sector	# 435
Overall Market	# 2106

Inventory Turnover Ratio Statistics
High	Average	Low
0.25	0.25	0.25
(Jun 30 2022)

CRXT Company Profile >> Back to CRXT Efficiency Comparisons >> Compare CRXT Inventory Turnover Ratio to its Competitors

Financial Statements
Clarus Therapeutics Holdings's Inventories	$ 17 Millions	Visit CRXT's Balance sheet
Clarus Therapeutics Holdings's Cost of Revenues TTM	$ 4 Millions	Visit CRXT's Income Statement
What are CRXT's Sales?		Visit CRXT's Sales by Segment

Other Inventory Turnover Ratios
Clarus Therapeutics Holdings's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CRXT's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CRXT's Competitors
Inventory Turnover Ratio for CRXT's Suppliers
Inventory Turnover Ratio for CRXT's Customers

You may also want to know
CRXT's Sales Growth Rates	CRXT's Pe Price to earnings ratio	CRXT's Receivables Turnover Ratio	CRXT's Stock Quote
CRXT's Net Income Growth Rates	CRXT's Ps Price to Sales ratio	CRXT's Sales per Employee	CRXT's Asset Turnover Ratio
CRXT's Net Margin	CRXT's Pb Price to Book ratio	CRXT's Financial Strength Ratios	CRXT's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2022, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2022	Inventories at quarter ending Jun 30 2022
Healthlynked Corp	0.54	$ 0.078 Millions	$ 0 Millions
Kyntra Bio Inc	0.48	$ 17.438 Millions	$ 36 Millions
Pulse Biosciences Inc	0.47	$ 2.980 Millions	$ 6 Millions
Abvc Biopharma Inc	0.45	$ 0.015 Millions	$ 0 Millions
Orthopediatrics Corp	0.43	$ 26.055 Millions	$ 61 Millions
Baudax Bio Inc	0.41	$ 2.047 Millions	$ 5 Millions
Trevena inc	0.41	$ 0.956 Millions	$ 2 Millions
Jaguar Health Inc	0.38	$ 1.997 Millions	$ 5 Millions
Delcath Systems Inc	0.34	$ 0.570 Millions	$ 2 Millions
Karyopharm Therapeutics Inc	0.30	$ 1.139 Millions	$ 4 Millions
Isoplexis Corporation	0.29	$ 8.556 Millions	$ 30 Millions
Motus Gi Holdings Inc	0.28	$ 0.194 Millions	$ 1 Millions
Eiger Biopharmaceuticals Inc	0.27	$ 0.683 Millions	$ 3 Millions
Rigel Pharmaceuticals Inc	0.27	$ 1.795 Millions	$ 7 Millions
Clarus Therapeutics Holdings Inc.	0.25	$ 3.623 Millions	$ 15 Millions
Clene Inc	0.25	$ 0.014 Millions	$ 0 Millions
Nemaura Medical Inc	0.25	$ 0.344 Millions	$ 1 Millions
Bionik Laboratories Corp	0.25	$ 0.265 Millions	$ 1 Millions
Deciphera Pharmaceuticals Inc	0.23	$ 3.616 Millions	$ 15 Millions
Palatin Technologies Inc	0.21	$ 0.217 Millions	$ 1 Millions
Marizyme Inc	0.14	$ 0.011 Millions	$ 0 Millions
One World Products Inc	0.13	$ 0.043 Millions	$ 0 Millions
Ibio inc	0.11	$ 0.216 Millions	$ 2 Millions
Guided Therapeutics Inc	0.11	$ 0.063 Millions	$ 1 Millions
Ptc Therapeutics inc	0.09	$ 1.400 Millions	$ 15 Millions
Biocryst Pharmaceuticals Inc	0.09	$ 1.491 Millions	$ 17 Millions
Global Blood Therapeutics Inc.	0.07	$ 4.452 Millions	$ 59 Millions
Arch Therapeutics Inc	0.06	$ 0.068 Millions	$ 1 Millions
Igc Pharma Inc	0.05	$ 0.222 Millions	$ 5 Millions

Date modified: 2026-09-08T15:10:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.